WO2002094009A3 - Procedes de selection et de production d'animaux presentant un niveau calcule de reponse immunitaire, de resistance ou de vulnerabilite aux maladies et/ou de productivite - Google Patents

Procedes de selection et de production d'animaux presentant un niveau calcule de reponse immunitaire, de resistance ou de vulnerabilite aux maladies et/ou de productivite Download PDF

Info

Publication number
WO2002094009A3
WO2002094009A3 PCT/CA2002/000733 CA0200733W WO02094009A3 WO 2002094009 A3 WO2002094009 A3 WO 2002094009A3 CA 0200733 W CA0200733 W CA 0200733W WO 02094009 A3 WO02094009 A3 WO 02094009A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
immune response
selecting
predicted level
animals
Prior art date
Application number
PCT/CA2002/000733
Other languages
English (en)
Other versions
WO2002094009A2 (fr
Inventor
Bruce N Wilkie
Bonnie A Mallard
Original Assignee
Guard Inc
Bruce N Wilkie
Bonnie A Mallard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guard Inc, Bruce N Wilkie, Bonnie A Mallard filed Critical Guard Inc
Priority to AU2002308331A priority Critical patent/AU2002308331A1/en
Priority to US10/477,742 priority patent/US20040235061A1/en
Priority to CA002487099A priority patent/CA2487099A1/fr
Priority to EP02771615A priority patent/EP1395114A2/fr
Publication of WO2002094009A2 publication Critical patent/WO2002094009A2/fr
Publication of WO2002094009A3 publication Critical patent/WO2002094009A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Cette invention porte sur des procédés de sélection d'animaux présentant un niveau calculé de réponse immunitaire, de résistance ou de vulnérabilité aux maladies et/ou de productivité fondés sur une valeur d'élevage espérée de la faculté de réponse immunitaire de l'animal. Cette invention porte également d'une part sur des procédés de production de groupes d'animaux présentant un niveau calculé de réponse immunitaire, de résistance ou de vulnérabilité aux maladies et/ou de productivité fondés sur la valeur d'élevage espérée, et d'autre part sur des procédés d'utilisation de tels animaux.
PCT/CA2002/000733 2001-05-24 2002-05-24 Procedes de selection et de production d'animaux presentant un niveau calcule de reponse immunitaire, de resistance ou de vulnerabilite aux maladies et/ou de productivite WO2002094009A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2002308331A AU2002308331A1 (en) 2001-05-24 2002-05-24 Methods for selecting and producing animals having a predicted level of immune response
US10/477,742 US20040235061A1 (en) 2001-05-24 2002-05-24 Methods for selecting and producing animals having a predicted level of immune response, disease resistance or susceptibility, and/or productivity
CA002487099A CA2487099A1 (fr) 2001-05-24 2002-05-24 Procedes de selection et de production d'animaux presentant un niveau calcule de reponse immunitaire, de resistance ou de vulnerabilite aux maladies et/ou de productivite
EP02771615A EP1395114A2 (fr) 2001-05-24 2002-05-24 Procedes de selection et de production d'animaux presentant un niveau calcule de reponse immunitaire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29296001P 2001-05-24 2001-05-24
US60/292,960 2001-05-24

Publications (2)

Publication Number Publication Date
WO2002094009A2 WO2002094009A2 (fr) 2002-11-28
WO2002094009A3 true WO2002094009A3 (fr) 2003-12-11

Family

ID=23126988

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2002/000733 WO2002094009A2 (fr) 2001-05-24 2002-05-24 Procedes de selection et de production d'animaux presentant un niveau calcule de reponse immunitaire, de resistance ou de vulnerabilite aux maladies et/ou de productivite

Country Status (5)

Country Link
US (1) US20040235061A1 (fr)
EP (1) EP1395114A2 (fr)
AU (1) AU2002308331A1 (fr)
CA (1) CA2487099A1 (fr)
WO (1) WO2002094009A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060260557A1 (en) * 2004-11-08 2006-11-23 Mccabe Michael Systems and methods for improving efficiencies in avian species
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
SG195652A1 (en) 2008-11-07 2013-12-30 Sequenta Inc Methods of monitoring conditions by sequence analysis
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
HUE029424T2 (en) 2009-01-15 2017-02-28 Adaptive Biotechnologies Corp Adaptive immunity profiling and a method for producing monoclonal antibodies
JP2012531202A (ja) 2009-06-25 2012-12-10 フレッド ハチンソン キャンサー リサーチ センター 適応免疫を測定する方法
US20140356339A1 (en) * 2011-09-09 2014-12-04 Sequenta Inc. Sequence-based measures of immune response
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
EP2768982A4 (fr) 2011-10-21 2015-06-03 Adaptive Biotechnologies Corp Quantification de génomes de cellules immunitaires adaptatives dans un mélange complexe de cellules
EP2788509B1 (fr) 2011-12-09 2018-07-11 Adaptive Biotechnologies Corporation Diagnostic des malignités lymphoïdes et détection de maladie résiduelle minimale
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
EP2823060B1 (fr) 2012-03-05 2018-02-14 Adaptive Biotechnologies Corporation Détermination de chaînes appariées de récepteurs immuns à partir de sous-unités présentant une fréquence correspondante
DK2831276T3 (da) 2012-05-08 2016-08-01 Adaptive Biotechnologies Corp Sammensætninger og fremgangsmåde til at måle og kalibrere amplifikations-bias i multipleks-PCR-reaktioner
ES2749118T3 (es) 2012-10-01 2020-03-19 Adaptive Biotechnologies Corp Evaluación de la inmunocompetencia por la diversidad de los receptores de inmunidad adaptativa y caracterización de la clonalidad
WO2015160439A2 (fr) 2014-04-17 2015-10-22 Adaptive Biotechnologies Corporation Quantification de génomes de cellules de l'immunité acquise dans un mélange complexe de cellules
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
WO2015134787A2 (fr) 2014-03-05 2015-09-11 Adaptive Biotechnologies Corporation Procédés dans lesquels on utilise des molécules synthétiques contenant des randomères
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
WO2016022614A1 (fr) * 2014-08-04 2016-02-11 Lafayette Christa Procédé permettant d'évaluer la santé et les prédispositions génétiques d'animaux
CA2966201A1 (fr) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corp. Detection simultanee hautement multiplexee d'acides nucleiques codant pour des heterodimeres de recepteurs de l'immunite adaptative apparies a partir de nombreux echantillons
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
US11066705B2 (en) 2014-11-25 2021-07-20 Adaptive Biotechnologies Corporation Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
AU2016222788B2 (en) 2015-02-24 2022-03-31 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
AU2016242967B2 (en) 2015-04-01 2021-07-01 Adaptive Biotechnologies Corp. Method of identifying human compatible T cell receptors specific for an antigenic target
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014064A1 (fr) * 1992-12-09 1994-06-23 University Of Guelph Methodologie pour developer une lignee superieure d'animaux domestiques

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014064A1 (fr) * 1992-12-09 1994-06-23 University Of Guelph Methodologie pour developer une lignee superieure d'animaux domestiques

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HERNANDEZ ARMANDO ET AL: "Evaluation of immune responses of cattle as a means to identify high or low responders and use of a human microarray to differentiate gene expression.", GENETICS SELECTION EVOLUTION (LES ULIS), vol. 35, no. Suppl. 1, 2003, pages S67 - S81, XP009018717, ISSN: 0999-193X (ISSN print) *
MALLARD B A ET AL: "Use of estimated breeding values in a selection index to breed Yorkshire pigs for high and low immune and innate resistance factors", ANIMAL BIOTECHNOLOGY, vol. 3, no. 2, 1992, pages 257 - 280, XP009018764, ISSN: 1049-5398 *
MALLARD B A, ET AL.: "IMMUNE RESPONSIVENESS IN SWINE: EIGHT GENERATIONS OF SELECTION FOR HIGH AND LOW IMMUNE RESPONSE IN YORKSHIRE PIGS.", PROCEEDINGS OF THE WORLD CONGRESS OF GENETICS APPLIED TOLIVESTOCK PRODUCTION, XX, XX, 1 January 1998 (1998-01-01), XX, pages 01 - 08, XP001155297 *
WILKIE BRUCE ET AL: "Selection for high immune response: An alternative approach to animal health maintenance?", VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, vol. 72, no. 1-2, 15 December 1999 (1999-12-15), pages 231 - 235, XP002257435, ISSN: 0165-2427 *
WILKIE ET AL.: ""Multitrait selection for immune response: a possible alternative strategy for enhanced livestock health and productivity"", WISEMAN, J, NOTTINGHAM UNIVERSITY PRESS, XP001155604 *

Also Published As

Publication number Publication date
US20040235061A1 (en) 2004-11-25
AU2002308331A1 (en) 2002-12-03
EP1395114A2 (fr) 2004-03-10
WO2002094009A2 (fr) 2002-11-28
CA2487099A1 (fr) 2002-11-28

Similar Documents

Publication Publication Date Title
WO2002094009A3 (fr) Procedes de selection et de production d'animaux presentant un niveau calcule de reponse immunitaire, de resistance ou de vulnerabilite aux maladies et/ou de productivite
NO974509L (no) Forankret flyttbar merd for oppdrett av fisk, skalldyr, o.l.
NO972033D0 (no) Ikke-diabetogene melk ellr melkeprodukter, samt fremgangsmåte til selektering av slike
JP2001515920A5 (fr)
AU2002366306A1 (en) Animal breeding system and utilization of the system
WO2006071107A8 (fr) Composition d'acariens, son utilisation, procede pour developper un acarien predateur des phytoseiides, systeme de developpement pour developper ledit acarien predateur des phytoseiides et procedes de controle biologique des ravageurs sur une recolte
SI1677623T1 (sl) Ĺ˝veäśilni izdelek za domaäśe ĺ˝ivali
WO2002082892A3 (fr) Dispositif d'entrainement d'animaux a systeme automatique
DK0888044T3 (da) Dyreøremærke
IT1303472B1 (it) Scarpetta particolarmente adatta per arrampicata libera.
HUP0301557A3 (en) Automatic horse training system
DE69834663D1 (de) Methode zur änderung der nährmittelzusammenstellung der milch die durch milchspendende tiere abgesonderd wird
CA2145028A1 (fr) Construction d'un piege ou d'une cage a homards
NZ334739A (en) Method of screening animals resistant or susceptible to diseases caused by intracellular parasites by analysing the bovine Nramp1 DNA sequence
USD496521S1 (en) 4 knots pet chew
WO2003008973A3 (fr) Marqueurs pour diagnostic
WO2003082206A3 (fr) Proteines derivees de l'immunoglobuline liees a la sclerose en plaques, compositions, methodes et utilisations relatives
WO2004074514A3 (fr) Methode de diagnostic du diabete de type 2 et de la forme a debut precoce de celui-ci
WO2002083727A3 (fr) Sequences d'acides nucleiques relatives a des hyperplasies et tumeurs de la glande thyroide
AU5409596A (en) A method of improving the chemical, physical and biological processes in agriculture, horticulture and animal husbandry and in humans
WO2001029230A3 (fr) Ingenierie de resistance aux maladies a l'aide de genes de type pectate lyase
WO2004018696A3 (fr) Procede permettant de determiner l'etat allelique de la terminaison 5' du gene de la caseine $g(a)s1
İşbir Finite element analysis of trimming process.
ATA129598A (de) Vorrichtung zur herstellung von granulat
WO2002006535A3 (fr) Procede d'elevage de volailles domestiquees resistantes aux maladies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002771615

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002771615

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10477742

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2487099

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2002771615

Country of ref document: EP